BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 19844856)

  • 1. Bacterial adhesion--a source of alternate antibiotic targets.
    Cusumano CK; Hultgren SJ
    IDrugs; 2009 Nov; 12(11):699-705. PubMed ID: 19844856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pilicides-small molecules targeting bacterial virulence.
    Aberg V; Almqvist F
    Org Biomol Chem; 2007 Jun; 5(12):1827-34. PubMed ID: 17551629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different drugs for bad bugs: antivirulence strategies in the age of antibiotic resistance.
    Dickey SW; Cheung GYC; Otto M
    Nat Rev Drug Discov; 2017 Jul; 16(7):457-471. PubMed ID: 28337021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antivirulence as a new antibacterial approach for chemotherapy.
    Escaich S
    Curr Opin Chem Biol; 2008 Aug; 12(4):400-8. PubMed ID: 18639647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-adhesion methods as novel therapeutics for bacterial infections.
    Cozens D; Read RC
    Expert Rev Anti Infect Ther; 2012 Dec; 10(12):1457-68. PubMed ID: 23253323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting virulence: a new paradigm for antimicrobial therapy.
    Clatworthy AE; Pierson E; Hung DT
    Nat Chem Biol; 2007 Sep; 3(9):541-8. PubMed ID: 17710100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel agents to inhibit microbial virulence and pathogenicity.
    Escaich S
    Expert Opin Ther Pat; 2010 Oct; 20(10):1401-18. PubMed ID: 20718591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel target sites in bacteria for overcoming antibiotic resistance.
    Black MT; Hodgson J
    Adv Drug Deliv Rev; 2005 Jul; 57(10):1528-38. PubMed ID: 15949866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The fallacies of hope: will we discover new antibiotics to combat pathogenic bacteria in time?
    Vicente M; Hodgson J; Massidda O; Tonjum T; Henriques-Normark B; Ron EZ
    FEMS Microbiol Rev; 2006 Nov; 30(6):841-52. PubMed ID: 17064283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biofilms and antibiotic therapy: is there a role for combating bacterial resistance by the use of novel drug delivery systems?
    Smith AW
    Adv Drug Deliv Rev; 2005 Jul; 57(10):1539-50. PubMed ID: 15950314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacterial resistance to antibiotics: active efflux and reduced uptake.
    Kumar A; Schweizer HP
    Adv Drug Deliv Rev; 2005 Jul; 57(10):1486-513. PubMed ID: 15939505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antivirulence drugs to target bacterial secretion systems.
    Baron C
    Curr Opin Microbiol; 2010 Feb; 13(1):100-5. PubMed ID: 20079679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel approaches to bacterial infection therapy by interfering with cell-to-cell signaling.
    Rasko DA; Sperandio V
    Curr Protoc Microbiol; 2009 Feb; Chapter 17():Unit17.3. PubMed ID: 19235150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nature's clarion call of antibacterial resistance: are we listening?
    Theuretzbacher U; Toney JH
    Curr Opin Investig Drugs; 2006 Feb; 7(2):158-66. PubMed ID: 16499286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Has nature already identified all useful antibacterial targets?
    Bumann D
    Curr Opin Microbiol; 2008 Oct; 11(5):387-92. PubMed ID: 18804175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The biological cost of mutational antibiotic resistance: any practical conclusions?
    Andersson DI
    Curr Opin Microbiol; 2006 Oct; 9(5):461-5. PubMed ID: 16890008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multi-targeting by monotherapeutic antibacterials.
    Silver LL
    Nat Rev Drug Discov; 2007 Jan; 6(1):41-55. PubMed ID: 17159922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting non-multiplying organisms as a way to develop novel antimicrobials.
    Coates AR; Hu Y
    Trends Pharmacol Sci; 2008 Mar; 29(3):143-50. PubMed ID: 18262665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Important bacterial gastrointestinal pathogens in children: a pathogenesis perspective.
    Amieva MR
    Pediatr Clin North Am; 2005 Jun; 52(3):749-77, vi. PubMed ID: 15925661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.